Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal rod cell | 9 studies | 35% ± 23% | |
retinal cone cell | 6 studies | 50% ± 32% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
eye | 3 studies | 39% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 96% | 59.39 | 163 / 170 | 2% | 0.04 | 7 / 459 |
ovary | 68% | 6.06 | 122 / 180 | 15% | 0.42 | 65 / 430 |
brain | 72% | 5.27 | 1891 / 2642 | 0% | 0.00 | 1 / 705 |
breast | 56% | 3.10 | 255 / 459 | 0% | 0 | 0 / 1118 |
adipose | 46% | 3.79 | 552 / 1204 | 0% | 0 | 0 / 0 |
prostate | 42% | 1.93 | 102 / 245 | 0% | 0 | 0 / 502 |
lung | 38% | 1.30 | 217 / 578 | 0% | 0 | 0 / 1155 |
spleen | 29% | 1.02 | 71 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 28% | 0.91 | 261 / 929 | 0% | 0 | 0 / 0 |
thymus | 25% | 0.79 | 161 / 653 | 2% | 0.05 | 13 / 605 |
adrenal gland | 27% | 0.86 | 69 / 258 | 0% | 0 | 0 / 230 |
stomach | 26% | 0.92 | 95 / 359 | 0% | 0 | 0 / 286 |
esophagus | 26% | 0.96 | 372 / 1445 | 0% | 0 | 0 / 183 |
muscle | 25% | 0.91 | 202 / 803 | 0% | 0 | 0 / 0 |
kidney | 25% | 0.79 | 22 / 89 | 0% | 0.00 | 1 / 901 |
blood vessel | 24% | 0.76 | 317 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 23% | 0.63 | 75 / 328 | 1% | 0.01 | 1 / 178 |
intestine | 23% | 0.73 | 223 / 966 | 0% | 0.01 | 1 / 527 |
heart | 23% | 0.74 | 197 / 861 | 0% | 0 | 0 / 0 |
skin | 21% | 1.01 | 382 / 1809 | 0% | 0 | 0 / 472 |
liver | 19% | 0.67 | 44 / 226 | 0% | 0.01 | 1 / 406 |
eye | 0% | 0 | 0 / 0 | 11% | 3.52 | 9 / 80 |
bladder | 5% | 0.14 | 1 / 21 | 0% | 0 | 0 / 504 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007601 | Biological process | visual perception |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | RAX2 |
Protein name | Retina and anterior neural fold homeobox protein 2 (Q50-type retinal homeobox protein) (Retina and anterior neural fold homeobox-like protein 1) |
Synonyms | QRX RAXL1 |
Description | FUNCTION: May be involved in modulating the expression of photoreceptor specific genes. Binds to the Ret-1 and Bat-1 element within the rhodopsin promoter. . |
Accessions | ENST00000555978.5 Q96IS3 ENST00000555633.3 |